| Mon, Nov 16, 2009 | | • | Crucell launches global brand to reflect and reinforce its leading position in healthcare innovation
Marketwire (Mon, Nov 16)
| | Tue, Nov 3, 2009 | | • | Crucell Announces Third Quarter 2009 Results
Marketwire (Tue, Nov 3)
| | Tue, Oct 27, 2009 | | • | Crucell to Release Q3 2009 Results on Tuesday November 3, 2009
Marketwire (Tue, Oct 27)
| | Wed, Oct 21, 2009 | | • | Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris
Marketwire (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | Crucell Rabies Monoclonal Antibody Combination: Positive Results Philippines Phase II Study Presented at RITA Conference
Marketwire (Tue, Oct 20)
| | Wed, Sep 30, 2009 | | • | Crucell Strengthens its Vaccine Sales in the UK with a Dedicated Marketing and Sales Organization
Marketwire (Wed, Sep 30)
| | Mon, Sep 28, 2009 | | • | Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment
Marketwire (Mon, Sep 28)
| | Tue, Aug 18, 2009 | | • | Crucell Receives NIH Award for the Development of Influenza Monoclonal Antibodies
Marketwire (Tue, Aug 18)
| | Mon, Aug 17, 2009 | | • | New awards of $300 million for Quinvaxem(R) bringing total value up to $800 million
Marketwire (Mon, Aug 17)
| | Tue, Aug 11, 2009 | | • | Crucell Announces Second Quarter 2009 Results
Marketwire (Tue, Aug 11)
| | Tue, Aug 4, 2009 | | • | Crucell to Release Q2 2009 Results on Tuesday August 11, 2009
Marketwire (Tue, Aug 4)
| | Wed, Jul 29, 2009 | | • | MVI and Crucell Announce Collaboration new Malaria Vaccine Approach
Marketwire (Wed, Jul 29)
| | Wed, Jun 24, 2009 | | • | Crucell Announces Positive Results of Phase II Rabies Monoclonal Antibody Combination Clinical Study in Philippines
Marketwire (Wed, Jun 24)
| | Fri, Jun 5, 2009 | | • | Crucell 2009 Annual General Meeting of Shareholders 2008 Financial Statements Adopted; All Resolutions Approved
Marketwire (Fri, Jun 5)
| | Wed, May 6, 2009 | | • | Crucell Announces First Quarter 2009 Results
Marketwire (Wed, May 6)
| | Wed, Apr 29, 2009 | | • | Crucell to Release First Quarter 2009 Results on Wednesday, May 6, 2009
Marketwire (Wed, Apr 29)
| | Tue, Apr 28, 2009 | | • | Aeras and Crucell Announce Start of TB Infant Study in South Africa
Marketwire (Tue, Apr 28)
| | Fri, Apr 24, 2009 | | • | Crucell Announces Release of 2008 Annual Report and Form 20-F
Marketwire (Fri, Apr 24)
| | Thu, Feb 26, 2009 | | • | Crucell's Revolutionary Antibody for Universal Therapy Against Flu
Marketwire (Thu, Feb 26)
| | Tue, Feb 10, 2009 | | • | DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins
Marketwire (Tue, Feb 10)
|
Add CRXL.AS News to My Yahoo!:
 
| |
|
0.39% Nasdaq 
Headlines
